Scientific Opinion on the substantiation of health claims related to folate  
and contribution to normal psychological functions (ID 81, 85, 86, 88),  
maintenance of normal vision (ID 83, 87), reduction of tiredness and  
fatigue (ID 84), cell division (ID 195, 2881) and contribution to normal  
amino acid synthesis (ID 195, 2881) pursuant to Article 13(1) of Regulation  
(EC) No 1924/2006[sup]1[/sup]  
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2, 3  
European Food Safety Authority (EFSA), Parma, Italy  
Słowa kluczowe:
Folate
 
amino acids synthesis
 
cell division
 
fatigue
 
folic acid
 
health claims
 
psychological functions
 
tiredness
 
vision
 
vitamin B9
 
	
	1. Charakterystyka żywności / składnika
	
        
		The food constituent that is the subject of the health claims is folate. Folate is measurable in foods by  established methods.
Folate is the generic name for a number of derivatives of pteroylglutamic acid (PGA, folic acid). Folic  acid is a synthetic folate compound used in food supplements and in food fortification because of its  stability, and which becomes biologically active after reduction. Natural (dietary) folates are mostly  reduced folates, i.e. derivatives of tetrahydrofolate (SCF, 2000).
Different forms of folate are authorised for addition to foods (Annex II of the Regulation (EC) No  1925/20066 and Annex II of Directive 2002/46/EC7). This evaluation applies to folate naturally  present in foods and those forms authorised for addition to foods (Annex II of the Regulation (EC) No  1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, folate, which is the subject of the health claims, is  sufficiently characterised.
		
	
	
    
	
	
		
 
	
	2. Znaczenie oświadczenia dla zdrowia człowieka
	
        
		
		
	
	
    
	
	
		
			
2.1. Udział w prawidłowym przebiegu funkcji psychicznych (psychologicznych) (ID 81, 85, 86, 88)
	
	
			The claimed effects are “mental performance (where mental performance stands for those aspects of  brain and nerve functions which determine aspects like concentration, learning, memory and  reasoning, as well as resistance to stress)”, “the role of vitamins and minerals in mental performance  (where mental performance stands for those aspects of brain and nerve functions which determine  aspects like concentration, learning, memory and reasoning)”, “cognitive function” and “cognitive  health”. The Panel assumes that the target population is the general population.
The Panel considers that contribution to normal psychological functions, which encompass cognitive  and affective domains, is a beneficial physiological effect.
	
    
			
	
		
			
2.2. Utrzymanie prawidłowego wzroku (ID 83, 87)
	
	
			The claimed effects are “eye health” and “eye health, folic acid with vitamin E and C”. The Panel  assumes that the target population is the general population.
The Panel considers that maintenance of normal vision is a beneficial physiological effect.
	
    
			
	
		
			
2.3. Zmniejszenie zmęczenia (ID 84)
	
	
			The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in situations  of inadequate micronutrient status”. The Panel assumes that the target population is the general  population.
The Panel considers that reduction of tiredness and fatigue is a beneficial physiological effect.
	
    
			
	
		
			
2.4. Podziały komórek (ID 195, 2881)
	
	
			The claimed effects are “la folate (vitamin B9) participe au métabolisme des protéines” and “cell  division/multiplication: nucleic acids and amino acids synthesis (such as in the gastrointestinal tract)”.  The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effect refers to normal cell  division.
A claim on folate and normal cell division has already been assessed with a favourable outcome  (EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2009).
	
    
			
	
		
			
2.5. Udział w prawidłowym tworzeniu aminokwasów (ID 195, 2881)
	
	
			The claimed effect are “la folate (vitamine B9) participe au métabolisme des protéines” and “cell  division/multiplication: nucleic acids and amino acids synthesis (such as in the gastrointestinal tract)”.  The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effect refers to normal  amino acid synthesis.
The Panel considers that contribution to normal amino acid synthesis is a beneficial physiological  effect.
	
    
			
	
		
 
	
	3. Naukowe uzasadnienia wpływu na zdrowie człowieka - 
	
        
		Folates play an important role in the transfer of C1-groups (i.e. methyl-, methylene- and formyl- groups), maintaining the methylation balance (SCF, 2000). Folate coenzymes are involved in  numerous reactions that involve DNA synthesis, purine synthesis, generation of formate into the  formate pool and amino acid interconversion (IoM, 1998).
		
	
	
    
	
	
		
			
3.1. Udział w prawidłowym przebiegu funkcji psychicznych (psychologicznych) (ID 81, 85, 86, 88)
	
	
			Severe folate deficiency in humans is characterised by macrocytic anaemia which produces symptoms  of weakness, fatigue, difficulty in concentrating, irritability, headache, palpitations and shortness of  breath (IoM, 1998).
The Panel concludes that a cause and effect relationship has been established between the dietary  intake of folate and contribution to normal psychological functions.
	
    
			
	
		
			
3.2. Utrzymanie prawidłowego wzroku (ID 83, 87)
	
	
			Thirteen references were provided for the substantiation of the claimed effect, including four  authoritative body reports, two reviews, one meta-analysis, five human studies and one consensus  report.
One reference provided regulatory provisions and most of the references addressed endpoints  unrelated to the claimed effect, including pregnancy outcomes, prevention of neural tube defects,  human reproduction and antioxidant activity. The Panel considers that no conclusions can be drawn  from these references for the scientific substantiation of the claimed effect.
A meta-analysis of case-control studies in patients with retinal vascular occlusive disease (Cahill et  al., 2003), a study by Kamburoglu et al. (2006) with patients diagnosed with age-related macular  degeneration and a longitudinal study in Pima Indians with Type 2 diabetes (Looker et al., 2003) were  not considered to be pertinent to the claimed effect because the Panel considers that the evidence  provided does not establish that patients with retinal vascular occlusive disease, patients with age- related macular degeneration or individuals with Type 2 diabetes are representative of the general  population with regard to normal vision.
The study of Taylor et al. (2002) evaluated the odds for early age-related cortical and posterior  subcapsular lens opacities and long term intake of vitamins and carotenoids in 492 non-diabetic  women aged 53–73 years and found that no nutrient intake measure was related to the prevalence of  opacities in the total sample. Sub-group analyses, however, indicated that there was a significant  correlation between folate intake and posterior subcapsular lens opacities in a subgroup of never- smokers (P=0.02); the Panel notes that the association with folate intake might be explained by the  high correlation (r=0.42) between folate and carotenoid intakes in their data-set and that diets high in  folate are also generally high in carotenoids.
In weighing the evidence, the Panel noted that the only human study presented was an  epidemiological study which did not show any effect of long term intake of folate from foods or  supplement use on the primary vision outcome measures.
The Panel concludes that a cause and effect relationship has not been established between the dietary  intake of folate and the maintenance of normal vision.
	
    
			
	
		
			
3.3. Zmniejszenie zmęczenia (ID 84)
	
	
			Insufficient intake of folate results in the deficiency condition of macrocytic anaemia. Symptoms of  weakness and fatigue typically appear at an advanced stage of anaemia or at milder degrees of  anaemia in some subjects (IoM, 1998).
The Panel concludes that a cause and effect relationship has been established between the dietary  intake of folate and the reduction of tiredness and fatigue.
	
    
			
	
		
			
3.4. Udział w prawidłowym tworzeniu aminokwasów (ID 195, 2881)
	
	
			Folate coenzymes are involved in amino acid interconversions, including the catabolism of histidine  to glutamic acid, interconversion of serine to glycine and remethylation of homocysteine to  methionine (IoM, 1998; FAO/WHO, 2002; Carmel, 2006). Folate-mediated transfer of single-carbon  units from serine provides a major source of substrate in single-carbon metabolism. The conversion of  homocysteine to methionine serves as a major source of methionine for the synthesis of S-adenosyl- methionine, which participates as the methyl donor in many biological methylation reactions of  proteins, nucleoproteins, histones, neurotransmitters and phospholipids (IoM, 1998; Carmel, 2006).
The Panel concludes that a cause and effect relationship has been established between the dietary  intake of folate and contribution to normal amino acids synthesis.
	
    
			
	
		
 
	
	4. Uwagi do zaproponowanego brzmienia oświadczenia
	
        
		
		
	
	
    
	
	
		
			
4.1. Udział w prawidłowym przebiegu funkcji psychicznych (psychologicznych) (ID 81, 85, 86, 88)
	
	
			The Panel considers that the following wording reflects the scientific evidence: “Folate contributes to  normal psychological functions”.
	
    
			
	
		
			
4.2. Zmniejszenie zmęczenia (ID 84)
	
	
			The Panel considers that the following wording reflects the scientific evidence: “Folate can contribute  to the reduction of tiredness and fatigue”.
	
    
			
	
		
			
4.3. Udział w prawidłowym tworzeniu aminokwasów (ID 195, 2881)
	
	
			The Panel considers that the following wording reflects the scientific evidence: “Folate contributes to  normal amino acid synthesis”.
	
    
			
	
		
 
	
	5. Warunki i możliwe ograniczenia stosowania oświadczenia
	
        
		The Panel considers that in order to bear the claims a food should be at least a source of folate as per  Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced  diet. The target population is the general population. Tolerable Upper Intake Levels (ULs) have been  established for folic acid for children and adults (SCF, 2000).
		
	
	
    
	
	
		
 
Wnioski
	
		On the basis of the data presented, the Panel concludes that:  
The Panel considers that the food constituent, folate, that is the subject of the health claim is  sufficiently characterised.  
Contribution to normal psychological functions (ID 81, 85, 86, 88)  
The claimed effects are “mental performance (where mental performance stands for those  aspects of brain and nerve functions which determine aspects like concentration, learning,  memory and reasoning, as well as resistance to stress)”, “the role of vitamins and minerals in  mental performance (where mental performance stands for those aspects of brain and nerve  functions which determine aspects like concentration, learning, memory and reasoning)”,  “cognitive function” and “cognitive health”. The target population is assumed to be the 
general population. Contribution to normal psychological functions, which encompass  cognitive and affective domains, is a beneficial physiological effect.  
A cause and effect relationship has been established between the dietary intake of folate and  contribution to normal psychological functions.   
The following wording reflects the scientific evidence: “Folate contributes to normal  psychological functions”.  
Maintenance of normal vision (ID 83, 87)  
The claimed effect is “eye health”, “eye health, folic acid with vitamin E and C”. The target  population is assumed to be the general population. Maintenance of normal vision is a  beneficial physiological effect.  
A cause and effect relationship has not been established between the dietary intake of folate  and the maintenance of normal vision.  
Reduction of tiredness and fatigue (ID 84)  
The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in  situations of inadequate micronutrient status”. The target population is assumed to be the  general population. Reduction of tiredness and fatigue is a beneficial physiological effect.  
A cause and effect relationship has been established between the dietary intake of folate and  the reduction of tiredness and fatigue.  
The following wording reflects the scientific evidence: “Folate can contribute to the reduction  of tiredness and fatigue”.  
Cell division (ID 195, 2881)  
The claimed effects are “la folate (vitamine B9) participe au métabolisme des protéines” and  “cell division/multiplication: nucleic acids and amino acids synthesis (such as in the  gastrointestinal tract)”. The target population is assumed to be the general population.   
A claim on folate and normal cell division has already been assessed with a favourable  outcome (EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009).  
Contribution to normal amino acid synthesis (ID 195, 2881)  
The claimed effects are “la folate (vitamin B9) participe au métabolisme des protéines” and  “cell division/multiplication: nucleic acids and amino acid synthesis (such as in the  gastrointestinal tract)”. The target population is assumed to be the general population.  Contribution to normal amino acids synthesis is a beneficial physiological effect.  
A cause and effect relationship has been established between the dietary intake of folate and  contribution to normal amino acids synthesis.  
The following wording reflects the scientific evidence: “Folate contributes to normal amino  acid synthesis”. 
Conditions and possible restrictions of use  
In order to bear the claims a food should be at least a source of folate as per Annex to  Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced  diet. The target population is the general population.